Загрузка...
A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression
Colon cancer has a high rate of recurrence even with good response to modern therapies. Novel curative adjuncts are needed. Oncolytic viral therapy has shown preclinical promise against colon cancer but lacks robust efficacy in clinical trials and raises regulatory concerns without real-time trackin...
Сохранить в:
| Опубликовано в: : | Mol Ther Oncolytics |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Gene & Cell Therapy
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6495072/ https://ncbi.nlm.nih.gov/pubmed/31061881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2019.04.001 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|